Genprex Inc (NASDAQ:GNPX)

1.79
Delayed Data
As of Aug 12
 +0.29 / +19.33%
Today’s Change
1.17
Today|||52-Week Range
3.62
+36.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$85.7M

Company Description

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company's lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.

Contact Information

Genprex, Inc.
3300 Bee Cave Road
Austin Texas 78746
P:(877) 774-4679
Investor Relations:

Employees

Shareholders

Mutual fund holders5.31%
Other institutional5.22%
Individual stakeholders14.32%

Top Executives

J. Rodney VarnerExecutive Chairman, President, CEO & Secretary
Ryan M. ConferChief Financial Officer
Mark S. BergerChief Medical Officer
Hemant KumarChief Manufacturing & Technology Officer
Kate CombsSenior Director-Clinical Operations